Regentis BiomaterialsRGNT
13F holders, Q2 2026 (June 30)6holders +3
4new positions
1sold out
1famous investor
$3.53avg. 13F price*
At the end of Q2 2026, 6 institutions reported holding Regentis Biomaterials Ltd. (RGNT) in their 13F filings, up 3 from Q1 2026. 4 opened new positions and 1 sold out. The largest holders were Rosalind Advisors, Inc. ($2.5M), Warberg Asset Management LLC ($306K) and Jane Street Group, LLC ($153K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Regentis Biomaterials Ltd.
- CUSIP
- M8211G108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $506K |
| Exits | 1 | $917K |
All 13F filers, Q1 2026 → Q2 2026: 593,947 shares bought and 300,000 shares sold, net +293,947 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Rosalind Advisors, Inc. | 0.93% | Add +179.0% | 701,685 | $2.5M |
| Warberg Asset Management LLC | 0.51% | New | 86,980 | $306K |
| Jane Street Group, LLC | 0.00% | New | 43,333 | $153K |
| Renaissance Technologies | 0.00% | New | 13,348 | $47K |
| UBS Group AG | 0.00% | Add +29.9% | 434 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 11 | $39 |
"% of holder's portfolio" is RGNT's weight in each manager's 13F, not the share of Regentis Biomaterials Ltd. the manager owns.